64.83 -0.05 (-0.08%)
After hours: 7:51PM EDT
|Bid||64.75 x 900|
|Ask||64.94 x 800|
|Day's range||64.25 - 65.22|
|52-week range||54.07 - 67.16|
|Beta (5Y monthly)||0.62|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||1.96 (3.06%)|
|Ex-dividend date||31 Mar 2021|
|1y target est||75.44|
Bristol Myers Squibb (NYSE: BMY) and Merck (NYSE: MRK) are two quintessential blue-chip healthcare stocks. Bristol Myers Squibb, which is almost 150 years old, has shown signs of rejuvenation and a bright future over the last few years. Bristol Myers also saw great developments for some of the top drugs currently in its pipeline.
BMS Presents New Research at ASCO & EHA 2021
In the latest trading session, Bristol Myers Squibb (BMY) closed at $64.70, marking a +0.4% move from the previous day.